Search Results - "Pallis, M"

Refine Results
  1. 1

    Analysis of factors that affect in vitro chemosensitivity of leukaemic stem and progenitor cells to gemtuzumab ozogamicin (Mylotarg) in acute myeloid leukaemia by Jawad, M, Seedhouse, C, Mony, U, Grundy, M, Russell, N H, Pallis, M

    Published in Leukemia (01-01-2010)
    “…Relapse in acute myeloid leukaemia (AML) is considered to result from the persistence of drug-resistant leukaemic stem and progenitor cells (LSPC) within a…”
    Get full text
    Journal Article
  2. 2

    Resistance to FLT3 inhibition in an in vitro model of primary AML cells with a stem cell phenotype in a defined microenvironment by Mony, U, Jawad, M, Seedhouse, C, Russell, N, Pallis, M

    Published in Leukemia (01-07-2008)
    “…Relapse in acute myeloid leukaemia (AML) is mediated by survival of leukaemic stem cells following remission-induction chemotherapy. It would therefore be…”
    Get full text
    Journal Article
  3. 3

    DNA repair contributes to the drug-resistant phenotype of primary acute myeloid leukaemia cells with FLT3 internal tandem duplications and is reversed by the FLT3 inhibitor PKC412 by SEEDHOUSE, C. H, HUNTER, H. M, LLOYD-LEWIS, B, MASSIP, A-M, PALLIS, M, CARTER, Gl, GRUNDY, M, SHANG, S, RUSSELL, N. H

    Published in Leukemia (01-12-2006)
    “…The presence of internal tandem duplications (ITD) mutations in the FMS-like tyrosine kinase 3 (FLT3) receptor influences the risk of relapse in acute myeloid…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Interleukin-1β maintains an apoptosis-resistant phenotype in the blast cells of acute myeloid leukaemia via multiple pathways by TURZANSKI, J, GRUNDY, M, RUSSELL, N. H, PALLIS, M

    Published in Leukemia (01-10-2004)
    “…Blast cell survival in suspension culture is associated with chemoresistance in acute myeloid leukaemia (AML). Autonomous production of IL-1β by AML blasts is…”
    Get full text
    Journal Article
  6. 6

    Analysis of the interaction of induction regimens with p-glycoprotein expression in patients with acute myeloid leukaemia: results from the MRC AML15 trial by Pallis, M, Hills, R, White, P, Grundy, M, Russell, N, Burnett, A

    Published in Blood cancer journal (New York) (01-06-2011)
    “…Retrospective analyses in non-randomised cohorts suggest that regimens containing fludarabine/Ara C and/or idarubicin/ara C may be more effective than…”
    Get full text
    Journal Article
  7. 7

    Resistance to spontaneous apoptosis in acute myeloid leukaemia blasts is associated with p‐glycoprotein expression and function, but not with the presence of FLT3 internal tandem duplications by Pallis, Monica, Turzanski, Julie, Grundy, Martin, Seedhouse, Claire, Russell, Nigel

    Published in British journal of haematology (01-03-2003)
    “…The ability of acute myeloid leukaemia (AML) blasts to survive in culture has been associated with poor patient response to chemotherapy. Other biological…”
    Get full text
    Journal Article
  8. 8

    Chronic rupture of a patellar tendon: a technique for reconstruction with Achilles allograft by Falconiero, R P, Pallis, M P

    Published in Arthroscopy (01-10-1996)
    “…Chronic ruptures of the patellar tendon fortunately are an uncommon event. These ruptures are often difficult to repair because they are generally accompanied…”
    Get more information
    Journal Article
  9. 9
  10. 10

    Ultrasound assessment of bladder volume: Is it valid after delivery? by Pallis, Lucinda M., Wilson, Melissa

    “…Aim:  To assess the validity of a commercially available bladder volume scanner in the puerperium. Methods:  A prospective blinded comparison of bladder volume…”
    Get full text
    Journal Article
  11. 11

    Early allogeneic transplantation for refractory or relapsed acute leukaemia following remission induction with FLAG by BYRNE, J. L, DASGUPTA, E, PALLIS, M, TURZANSKI, J, FORMAN, K, MITCHELL, D, HAYNES, A, RUSSELL, N

    Published in Leukemia (01-05-1999)
    “…The prognosis for patients with secondary AML, primary resistant AML or ALL and early (<12 months) relapse of acute leukaemia remains extremely poor with…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Use of standardized flow cytometric determinants of multidrug resistance to analyse response to remission induction chemotherapy in patients with acute myeloblastic leukaemia by Pallis, M., Turzanski, J., Harrison, G., Wheatley, K., Langabeer, S., Burnett, A. K., Russell, N. H.

    Published in British journal of haematology (01-02-1999)
    “…We have used a combination of flow cytometric assays to define multidrug resistance (MDR) positive and negative blasts in cryopreserved samples from 47 MRC…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Strategy for Naturelike Designer Transcription Factors with Reduced Toxicity by Bach, Christian, Patra, Prabir K., Pallis, Jani M., Sherman, William B., Bajwa, Hassan

    “…For clinical applications, the biological functions of DNA-binding proteins require that they interact with their target binding site with high affinity and…”
    Get full text
    Journal Article
  16. 16

    Functional multidrug resistance in acute myeloblastic leukaemia : a standardized flow cytometric assay for intracellular daunorubicin accumulation by PALLIS, M, RUSSELL, N. H

    Published in British journal of haematology (1998)
    “…We have developed a standardized flow cytometric method for the measurement of in vitro multidrug resistance in acute myeloblastic leukaemia (AML) blasts,…”
    Get full text
    Journal Article
  17. 17

    Blast maturity and CD34 expression determine the effects of the differentiating agents KH1060 and 9-cis-retinoic acid on the differentiation and clonogenicity of non-M3 acute myeloid leukaemia cells by PALLIS, M, TURZANSKI, J, RUSSELL, N. H

    Published in Leukemia (01-11-1998)
    “…The vitamin D analogue KH1060 and the retinoids all-trans retinoic acid (ATRA), 9-cis-retinoic acid (9-cRA) and 4-hydroxyphenyl retinamide (4-HPR) induce…”
    Get full text
    Journal Article
  18. 18

    Reproducible flow cytometric methodology for measuring multidrug resistance in leukaemic blasts by Pallis, M, Turzanski, J, Langabeer, S, Russell, N H

    “…In order to bring MDR analysis into a clinical setting, reproducible assays with clear cut off points to define MDR positivity must be used. Sensitivity can…”
    Get more information
    Journal Article
  19. 19

    P-glycoprotein plays a drug-efflux–independent role in augmenting cell survival in acute myeloblastic leukemia and is associated with modulation of a sphingomyelin-ceramide apoptotic pathway by Pallis, Monica, Russell, Nigel

    Published in Blood (01-05-2000)
    “…P-glycoprotein (pgp), which is the product of the MDR1(multidrug resistance-1) gene, has an established role as a mediator of cytotoxic drug resistance in…”
    Get full text
    Journal Article
  20. 20

    Nailfold capillary density as a possible indicator of pulmonary capillary loss in systemic lupus erythematosus but not in mixed connective tissue disease by Pallis, M, Hopkinson, N, Powell, R

    Published in Journal of rheumatology (01-10-1991)
    “…Nailfold capillary density was measured in 24 patients with systemic lupus erythematosus (SLE), 14 with mixed connective tissue disease (MCTD) and 21 healthy…”
    Get more information
    Journal Article